Recombinant vaccine using flavivirus as vector

A yellow fever virus and carrier technology, applied in the fields of virology and immunology, can solve the problems of potential safety hazards, high cytotoxicity, unsatisfactory cleavage effect of proteolytic cleavage sites, etc.

Active Publication Date: 2005-06-22
上海天甲生物医药有限公司 +2
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] (1) Most people (55%) have adenovirus antibodies in their bodies. When vaccinated, the antibodies combine with the adenovirus vector, which seriously affects the vaccine effect;
[0014] (2) When the titer is high, t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant vaccine using flavivirus as vector
  • Recombinant vaccine using flavivirus as vector
  • Recombinant vaccine using flavivirus as vector

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] Preparation of full-length cDNA clone of yellow fever virus vaccine

[0093] The construction process is shown in Figure 1. figure 2 , image 3 Shown:

[0094] 1. The full-length yellow fever virus vaccine cDNA is integrated into the pRS424 plasmid (Plasmid), and the yellow fever virus vaccine Yellow Fever virus Strain 17D (YF 17D) and pRS424 plasmid (ATCC#: 77105) are purchased from American Type Culture Collection (ATCC).

[0095] a) Convert the RNA of yellow fever virus YF 17D into three yellow fever virus cDNA fragments (5' end cDNA, 3' end cDNA and middle cDNA) by RT-PCR method. Add Not I restriction site and Sp6 enhancer sequence at the 5' end; EcoR I restriction site of YF cDNA at the 3' end of the 5' end cDNA fragment; add Xho at the 3' end of the 3' end fragment I restriction site; The two ends of the middle fragment include part of the same gene sequence as the 3' end of the 5' end cDNA fragment and the 5' end of the 3' end cDNA fragment.

[0096] ...

Embodiment 2

[0101] Prepare the SARS vaccine (the insertion site is 4572-4573nt of the yellow fever virus genome) modified by the gene fragment (2A) of the foot-and-mouth disease virus between NS2B and NS3 of the yellow fever virus cDNA

[0102] Build process like Figure 4 shown.

[0103] 1. the full-length yellow fever virus cDNA clone that embodiment 1 obtains cuts out an about 2.2kb long fragment with Kpn I endonuclease and Nhe I endonuclease, and this fragment comprises the 3445th of yellow fever virus cDNA sequence The base at position -5576.

[0104] 2.以黄热病病毒cDNA克隆为模板,分别以GGATACAAGGTTCAGACGAAC(SEQ ID NO:10)和AACCATCGATTCGGGGCCAGGGTTGGACTCGTCTCCCGCAAGCTTAAGAAGGTCA AAATTCAACAGCTGCATATGCCACAAGACATCCCCACTTCTC(SEQ ID NO:11)为一对引物;并以AACCCTGGCCCCGAATCGATGGTTCGAGGCGCGCGACGCAGCGGTGACGTACTCTGGGATAT TCCCACTCCTAAGATCATC(SEQ IDNO:12)和CGCTGCCCAACCTCTAGCGGC( SEQ ID NO: 13) is another pair of primers, then use the PCR method to produce two DNA fragments, in which a 2A gene sequence is introduced, an...

Embodiment 3

[0114] Prepare the SARS vaccine (the insertion site is 2453-2454nt of the yellow fever virus genome) modified by the gene fragment (2A) of the foot-and-mouth disease virus between E and NS1 of the yellow fever virus cDNA

[0115] Build process like Figure 5 shown.

[0116] 1. Cut out a fragment about 1 kb in length from the full-length yellow fever virus cDNA clone with Pst I. This fragment includes positions 1959-2782 of the yellow fever virus cDNA sequence.

[0117] 2.以黄热病病毒cDNA克隆为模板,分别以GTCAAGAACCCAACTGACACT(SEQ ID NO:18)和AAGGTCAAAATTCAACAGCTGAAAGAAGATGGCGCATCCTTG(SEQ ID NO:19)为一对引物;并以CAGCTGTTGAATTTTGACCTTCTTAAGCTTGCGGGAGACGTCGAGTCCAACCCTGGCCCCAACATGACAATGTCCATGAGC(SEQ ID NO:20)和CCAGACCCGGTTTGAAAACGG(SEQ ID NO: 21) is another pair of primers, then use the PCR method to produce two DNA fragments, in which a 2A gene sequence is introduced, and the 2A gene sequence is the gene fragment of foot-and-mouth disease virus (SEQ ID NO: 1 ). The above-mentioned two DNA fragments a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a yellow fever virus vector, in which an exogenous polypeptide expression module is inserted into its genome, and the expression module has in sequence from 5' to 3': (a) a release element at the 5' end; (b) an exogenous polypeptide encoding The gene element of source polypeptide; And (c) 3 ' terminal release element, described release element is selected from: the nucleotide sequence of coding foot-and-mouth disease virus autohydrolase, the nucleotide sequence of coding signal peptide hydrolase substrate, and its combination. The carrier can provide antigenic polypeptides of viruses and tumors in host cells, thereby triggering immune responses against viruses and tumors.

Description

technical field [0001] The invention relates to the fields of virology and immunology, and more specifically relates to a yellow fever virus vector expressing foreign polypeptide (such as an antigen) and a recombinant vaccine containing the vector. Background technique [0002] Yellow fever virus (yellow fever vaccine, YFV) is spherical, with a diameter of 40-50nm. It is composed of an envelope and a nucleocapsid. The nucleocapsid is composed of a capsid protein (C) and nucleic acid. The protein (E) spikes, and there is an inner membrane protein (M) in the envelope, which participates in the assembly of the virus. The virus genome is a single-stranded positive-strand RNA with a total length of 11kb, which encodes structural proteins C, M, E and non-structural proteins NS1-NS5 in sequence from the 5' to 3' end. Viral RNA directly acts as mRNA in the cytoplasm and translates out Structural and nonstructural proteins. [0003] Yellow fever (yellow fever, YF) caused by yellow ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K48/00C12N7/01C12N15/33C12N15/63C12N15/86
CPCY02A50/30
Inventor 庞小伍顾心彬
Owner 上海天甲生物医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap